• 1.

    Aymé S, et al.; Conference Participants. Common elements in rare kidney diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2017; 92:796808. doi: 10.1016/j.kint.2017.06.018

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Wong K, et al.; RaDaR Consortium. Effects of rare kidney diseases on kidney failure: A longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. Lancet 2024; 403:12791289. doi: 10.1016/S0140-6736(23)02843-X

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Wühl E, et al. Renal replacement therapy for rare diseases affecting the kidney: An analysis of the ERA-EDTA Registry. Nephrol Dial Transplant 2014; 29(Suppl 4):iv1iv8. doi: 10.1093/ndt/gfu030

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Lake BB, et al.; KPMP Consortium. An atlas of healthy and injured cell states and niches in the human kidney. Nature 2023; 619:585594. doi: 10.1038/s41586-023-05769-3

    • PubMed
    • Search Google Scholar
    • Export Citation

Gaining a Deeper Understanding of Rare Kidney Diseases: Insights from RaDaR

Muhammad A. Mujtaba Muhammad A. Mujtaba, MD, FASN, and Divya Monga, MD, are associate professors in the Division of Nephrology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston.

Search for other papers by Muhammad A. Mujtaba in
Current site
Google Scholar
PubMed
Close
and
Divya Monga Muhammad A. Mujtaba, MD, FASN, and Divya Monga, MD, are associate professors in the Division of Nephrology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston.

Search for other papers by Divya Monga in
Current site
Google Scholar
PubMed
Close
Restricted access
Save